Gabapentin in Treatment of Muscle Cramps in Patients With Liver Cirrhosis

NCT02642484 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2018-01-03

No results posted yet for this study

Summary

* Muscle cramps markedly affect the quality of life in cirrhotic patients with no highly effective drug.
* Quinine was suggested for treatment of patients with muscle cramps in patients with liver cirrhosis. However, thrombocytopenia, cardiac arrhythmias and cinchonism are serious side effects.

Conditions

Interventions

DRUG

Gabapentin

Gapapentin twice daily

DRUG

Calcium Carbonate

calcium carbonate twice daily

Sponsors & Collaborators

  • Tanta University

    lead OTHER

Principal Investigators

  • Sherief M. Abd-Elsalam, Consultant · Hepatology and gastroenterology dept.-Tanta

  • A. K. Singal, Professor · Division of Gastroenterology and Hepatology, UAB, Birmingham, AL, USA

  • Walaa A. Elkhalawany, Lecturer · Hepatology and gastroenterology dept.-Tanta

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-12-31
Primary Completion
2022-12-31
Completion
2022-12-31

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02642484 on ClinicalTrials.gov